PRINCETON, N.J., Feb. 8, 2017 /PRNewswire/ -- Quartesian, a leading data CRO known for delivering “Clinical Data Your Way” for Phase 1, Generic Clinical Endpoint studies and small-to-midsized Biotechs, today announced record yearly contract bookings and revenue for 2016.
Highlights for Quartesian’s record breaking 2016 included:
- Record YTD contract bookings and revenue revenue increase of 61% versus 2015
- New customers: including two of the top five CROs and three of top five Generics
- 13 new clients signed in 2016
- Pipeline increase of over 70% since start of 2015
- 14 straight years of revenue growth, positive cash flow and no debt
“These results demonstrate that the life science market is ready for ‘Clinical Data Your Way’ -- quality clinical data services delivered quickly and at very affordable prices,” said Benjamin Jackson, CEO, Quartesian. “Demand for our unique blend of experienced onshore project managers coupled with high quality, value driven offshore resources has been broad-based across the industry.”
Quartesian is the perfect fit for Generics, small-to-midsize biopharma, and Phase I studies as their expertise and technology platform has the ability to deliver the quality data they need faster, and more cost-efficiently than they’d ever thought possible. Quartesian is also a valuable resource for CROs who need the flexibility to add expert SAS and Medidata Rave resources on demand. They have provided thousands of CDISC SDTM datasets to their customers while maintaining an unparalleled track record including serving 100+ clients, and enjoying 100% repeat business all with zero change orders. These metrics and offerings continue to drive the success seen in 2016.
Quartesian will be exhibiting at the Generic Pharmaceutical Association (GPhA) annual meeting in Orlando February 13-15.
About Quartesian
Quartesian LLC was formed in January 2003 and is headquartered in Princeton, N.J. with the goal of providing world-class clinical development services to its clients. Quartesian prides itself on delivering “Clinical Data Your Way”, building a reputation for value- added quality, flexibility, responsiveness, adherence to client specifications and timelines for all projects conducted anywhere in the world. Now in our Fourteenth year, we have worked for over 100 pharmaceutical, biotechnology and medical device companies, with 100% repeat business. Learn more about Quartesian at www.quartesian.com.
Media Contact:
Stephen Boccardo
Sr. VP Business Development and Commercial Strategy
609.454.3312
stephen.boccardo@quartesian.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/quartesian-posts-record-results-for-2016-as-trusted-clinical-data-management-partner-300403759.html
SOURCE Quartesian
